Today, FDA issued diagnostic EUAs to GenMark Diagnostics, Inc. for its ePlex SARS-CoV-2 Test and Diasorin Molecular LLC for its Simplexa COVID-19 Direct https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations#covid19ivd   … pic.twitter.com/yMY3zf8PbH

Today, FDA issued diagnostic EUAs to GenMark Diagnostics, Inc. for its ePlex SARS-CoV-2 Test and Diasorin Molecular LLC for its Simplexa COVID-19 Direct https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations#covid19ivd … pic.twitter.com/yMY3zf8PbH

Source: Food and Drug Adminstration (FDA): CDRHNew - March 20, 2020 Category: Medical Devices Authors: ( at SteveFDA) Source Type: news